Jordan vs Lao People's Democratic Republic: Antiretroviral therapy coverage
Jordan
64.0%
in 2024
Lao People's Democratic Republic
64.0%
in 2024
Jordan rank
97th
Lao People's Democratic Republic rank
97th
Antiretroviral therapy coverage over time
- Jordan
- Lao People's Democratic Republic
How they compare
Jordan currently reports 64.0% against 64.0% in Lao People's Democratic Republic, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Jordan ahead.
Jordan ranks 97th and Lao People's Democratic Republic ranks 97th of 143 countries.
Across the 3 decades both report, Jordan averaged higher in 2 and Lao People's Democratic Republic in 1.
Head to head by decade
| Decade | Jordan | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.3% | 6.0% | 12.3% | Jordan |
| 2010s | 41.9% | 29.6% | 12.3% | Jordan |
| 2020s | 54.0% | 54.6% | 0.6% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Jordan or Lao People's Democratic Republic?
- Jordan, at 64.0% against 64.0% in Lao People's Democratic Republic as of 2024.
- What is the difference in antiretroviral therapy coverage between Jordan and Lao People's Democratic Republic?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Lao People's Democratic Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Jordan and Lao People's Democratic Republic rank globally for antiretroviral therapy coverage?
- Jordan ranks 97th and Lao People's Democratic Republic ranks 97th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.